Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A bioinspired polymeric membrane-enclosed insulin crystal achieves long-term, self-regulated drug release for type 1 diabetes therapy

Abstract

The nuclear envelope serves as a highly regulated gateway for macromolecule exchange between the nucleus and cytoplasm in eukaryotes. Here we have developed a cell nucleus-mimicking polymeric membrane-enclosed system for long and self-regulated therapy. A polymeric nano-membrane with nanopores is conformally synthesized in situ on the surface of each insulin crystal, ensuring sustained, adjustable and zero-order drug release kinetics. Glucose- and β-hydroxybutyrate-dually sensitive microdomains are integrated into the nano-membranes. Under a normal state, the microdomains are uncharged and the channel is narrow enough to block insulin outflow. Under hyperglycaemia and ketonaemia, microdomains convert the high glucose and β-hydroxybutyrate concentration signals to the negative electric potential of membranes, widening the nanopores with rapid insulin outflow. In type 1 diabetic mice and minipigs, this system can maintain normoglycaemia for longer than 1 month and 3 weeks, respectively, with validated glucose- and β-hydroxybutyrate-triggered insulin release. Such membrane-enclosed drug crystal/powder formulation provides a broad platform for long-acting controlled release.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematic and preparation of i-crystal.
Fig. 2: In vitro insulin release of i-crystal.
Fig. 3: Treatment efficacy of i-crystal in type 1 diabetic mice.
Fig. 4: Evaluation of i-crystal-3 in type 1 diabetic pigs.
Fig. 5: Biosafety of i-crystal.

Similar content being viewed by others

Data availability

All data supporting the findings of this study are presented in the paper and the Supplementary Information. Source data are provided with this paper.

References

  1. Paine, P. L., Moore, L. C. & Horowitz, S. B. Nuclear envelope permeability. Nature 254, 109–114 (1975).

    Article  CAS  PubMed  Google Scholar 

  2. Ungricht, R. & Kutay, U. Mechanisms and functions of nuclear envelope remodelling. Nat. Rev. Mol. Cell Biol. 18, 229–245 (2017).

    Article  CAS  PubMed  Google Scholar 

  3. Mekhail, K. & Moazed, D. The nuclear envelope in genome organization, expression and stability. Nat. Rev. Mol. Cell Biol. 11, 317–328 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ohno, M., Fornerod, M. & Mattaj, I. W. Nucleocytoplasmic transport: the last 200 nanometers. Cell 92, 327–336 (1998).

    Article  CAS  PubMed  Google Scholar 

  5. Fahrenkrog, B. & Aebi, U. The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat. Rev. Mol. Cell Biol. 4, 757–766 (2003).

    Article  CAS  PubMed  Google Scholar 

  6. Terry, L. J., Shows, E. B. & Wente, S. R. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318, 1412–1416 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. Wente, S. R. & Rout, M. P. The nuclear pore complex and nuclear transport. CSH Perspect. Biol. 2, a000562 (2010).

    CAS  Google Scholar 

  8. Mudumbi, K. C. et al. Nucleoplasmic signals promote directed transmembrane protein import simultaneously via multiple channels of nuclear pores. Nat. Commun. 11, 2184 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Mohr, D., Frey, S., Fischer, T., Güttler, T. & Görlich, D. Characterisation of the passive permeability barrier of nuclear pore complexes. EMBO J. 28, 2541–2553 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kahms, M., Lehrich, P., Hüve, J., Sanetra, N. & Peters, R. Binding site distribution of nuclear transport receptors and transport complexes in single nuclear pore complexes. Traffic 10, 1228–1242 (2009).

    Article  CAS  PubMed  Google Scholar 

  11. Nakielny, S. & Dreyfuss, G. Transport of proteins and RNAs in and out of the nucleus. Cell 99, 677–690 (1999).

    Article  CAS  PubMed  Google Scholar 

  12. Görlich, D. & Kutay, U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15, 607–660 (1999).

    Article  PubMed  Google Scholar 

  13. Macara, I. G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65, 570–594 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Dalbey, D. & von Heijne, G. (eds) Protein Targeting, Transport, and Translocation (Elsevier, 2002).

  15. Hinshaw, J. E. & Milligan, R. A. Nuclear pore complexes exceeding eightfold rotational symmetry. J. Struct. Biol. 141, 259–268 (2003).

    Article  CAS  PubMed  Google Scholar 

  16. Beck, M. et al. Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science 306, 1387–1390 (2004).

    Article  CAS  PubMed  Google Scholar 

  17. Lim, R. Y. et al. Flexible phenylalanine–glycine nucleoporins as entropic barriers to nucleocytoplasmic transport. Proc. Natl Acad. Sci. USA 103, 9512–9517 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Panté, N. & Kann, M. Nuclear pore complex is able to transport macromolecules with diameters of ~39 nm. Mol. Biol. Cell 13, 425–434 (2002).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kosako, H. & Imamoto, N. Phosphorylation of nucleoporins: signal transduction-mediated regulation of their interaction with nuclear transport receptors. Nucleus 1, 1026–1035 (2010).

    Article  Google Scholar 

  20. Komeili, A. & O’Shea, E. K. Roles of phosphorylation sites in regulating activity of the transcription factor Pho4. Science 284, 977–980 (1999).

    Article  CAS  PubMed  Google Scholar 

  21. De Souza, C. P. & Osmani, S. A. Mitosis, not just open or closed. Eukaryot. Cell 6, 1521–1527 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Xu, Z., Hueckel, T., Irvine, W. T. M. & Sacanna, S. Transmembrane transport in inorganic colloidal cell-mimics. Nature 597, 220–224 (2021).

    Article  CAS  PubMed  Google Scholar 

  23. Zhu, S. et al. Voltage-mediated water dynamics enables on-demand transport of sugar molecules in two-dimensional channels. Angew. Chem. Int. Ed. Engl. 62, e202309024 (2023).

    Article  CAS  PubMed  Google Scholar 

  24. Shen, J., Liu, G., Han, Y. & Jin, W. Artificial channels for confined mass transport at the sub-nanometre scale. Nat. Rev. Mater. 6, 294–312 (2021).

    Article  CAS  Google Scholar 

  25. Møller, N. Ketone body, 3-hydroxybutyrate: minor metabolite–major medical manifestations. J. Clin. Endocrinol. Metab. 105, dgaa370 (2020).

    Article  PubMed  Google Scholar 

  26. Malaisse, W. J. et al. Ketone bodies and islet function: 45Ca handling, insulin synthesis, and release. Am. J. Physiol. 259, E117–E122 (1990).

    CAS  PubMed  Google Scholar 

  27. Hirobata, T. et al. Serum ketone body measurement in patients with diabetic ketoacidosis. Diabetol. Int. 13, 624–630 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  28. Laracuente, M.-L., Yu, M. H. & McHugh, K. J. Zero-order drug delivery: state of the art and future prospects. J. Control. Release 327, 834–856 (2020).

    Article  CAS  PubMed  Google Scholar 

  29. Li, W. et al. Clinical translation of long-acting drug delivery formulations. Nat. Rev. Mater. 7, 406–420 (2022).

    Article  Google Scholar 

  30. Teng, R. et al. Comparison of protocols to reduce diabetic ketoacidosis in patients with type 1 diabetes prescribed a sodium–glucose cotransporter 2 inhibitor. Diabetes Spectr. 34, 42–51 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wang, J. et al. Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs. Sci. Adv. 5, eaaw4357 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ayala, J. E. et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Models Mech. 3, 525–534 (2010).

    Article  CAS  Google Scholar 

  33. Lee, J. Y. et al. Persicarin isolated from Oenanthe javanica protects against diabetes-induced oxidative stress and inflammation in the liver of streptozotocin-induced type 1 diabetic mice. Exp. Ther. Med. 13, 1194–1202 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Krause, M. P. et al. Diabetic myopathy differs between Ins2Akita+/− and streptozotocin-induced type 1 diabetic models. J. Appl. Physiol. 106, 1650–1659 (2009).

    Article  CAS  PubMed  Google Scholar 

  35. Yeo, H. J. et al. Protective effects of Tat-DJ-1 protein against streptozotocin-induced diabetes in a mice model. BMB Rep. 51, 362–367 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Mo, J. et al. Blood metabolic and physiological profiles of Bama miniature pigs at different growth stages. Porcine Health Manag. 8, 35 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Key R&D Program of China (2022YFE0202200, J.W.), the Key R&D Program of Zhejiang Province (2024C03085, J.W.), the National Natural Science Foundation of China (32471374, J.W.), the Zhejiang University’s Start-up Packages, the Starry Night Science Fund at Shanghai Institute for Advanced Study of Zhejiang University (SN-ZJU-SIAS-009, J.W.), the Postdoctoral Fund of Zhejiang Province (ZJ2023044, J.X.) and the Postdoctoral Fellowship Program of CPSF (GZB20240669, L.L.). We thank J. Pan in the Research and Service Center, College of Pharmaceutical Sciences, Zhejiang University, for performing NMR spectrometry for structure elucidation and G. Zhu, D. Song and L. Wu in the Center of Cryo-Electron Microscopy (CCEM), Zhejiang University, for their technical assistance on scanning electron microscopy, energy-dispersive X-ray spectroscopy mapping and cryo-transmission electron microscopy. We appreciate the help from D. Guo (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine) for slicing and staining skin tissue, X. Zhao (Bio-ultrastructure Analysis Lab of Analysis Center of Agrobiology and Environmental Sciences, Zhejiang University) for frozen slicing of materials, C. Sun and L. Mao (Analysis Center of Agrobiology and Environmental Sciences, Zhejiang University) for MALDI-TOF mass analysis and FTIR spectrum, as well as D. Xu, M. Zhang, J. Chen and S. Xiong (Animal Center, Zhejiang University) for taking care of pigs.

Author information

Authors and Affiliations

Authors

Contributions

J.X. and Y.Z. contributed equally to this work. Z.G., J.W. and S.Z. conceived and designed the study. J.X., Y.Z., J.Z., W.L., K.J., G.X., P.W., X.W., S.M., L.L., Y.Y., F.L. and Y.M. conducted the experiments and obtained related data. J.Z. and J.W. gave experimental operation teaching and theoretical guidance on host response evaluation. Y.W., J.Y. and Z.G. designed and drew the schematic of this article. J.X., Y.Z., J.W., J.B.B., J.G. and Z.G. analysed the data and wrote the paper.

Corresponding authors

Correspondence to Jinqiang Wang or Zhen Gu.

Ethics declarations

Competing interests

Z.G. and J.W. have applied for patents related to this study (PCT/CN2024/081997 and 2024102784888). Z.G. is the co-founder of Zenomics Inc., Zcapsule Inc. and μZen Inc. The other authors declare no competing interests.

Peer review

Peer review information

Nature Nanotechnology thanks Eric Appel and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

Source Data Fig. 1 (download XLSX )

Statistical source data for Fig. 1.

Source Data Fig. 2 (download XLSX )

Statistical source data for Fig. 2.

Source Data Fig. 3 (download XLSX )

Statistical source data for Fig. 3.

Source Data Fig. 4 (download XLSX )

Statistical source data for Fig. 4.

Source Data Fig. 5 (download XLSX )

Statistical source data for Fig. 5.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Zhang, Y., Zhao, S. et al. A bioinspired polymeric membrane-enclosed insulin crystal achieves long-term, self-regulated drug release for type 1 diabetes therapy. Nat. Nanotechnol. 20, 697–706 (2025). https://doi.org/10.1038/s41565-025-01860-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41565-025-01860-0

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research